OpGen, Inc. announced that David E. Lazar got appointed to the Board of Directors. In addition, effective as of the initial closing, each of the prior members of the Company?s board of directors resigned and. In addition to the appointment of Mr. Lazar as a director, each of Messrs.

Avraham Ben-Tzvi, Matthew McMurdo, and David Natan were also appointed to the board of the Company, effective as of the initial closing on March 25, 2024. David E. Lazar (33) has served as the Chief Executive Officer of Titan Pharmaceuticals Inc., where he also served as a director and board chairman from August 2022 until October 2023. On December 28, 2023, Mr. Lazar was appointed Chief Executive Officer and to the board of directors of Minim, Inc. Mr. Lazar has successfully served as a custodian to numerous public companies across a wide range of industries, including without limitation, C2E Energy, Inc., China Botanic Pharmaceutical Inc., One 4 Art Ltd., Romulus Corp., Moveix, Inc., Arax Holdings Corp., ESP Resitsces, Inc., Adorbs, Inc., Exobox Technologies Corp., Petrone Worldwide, Inc., Superbox, Inc., Sino Green Land Corp., SIPP International Industries, Inc., Cereplast, Inc, Energy 1 Corp., ForU Holdings, Inc., China Yanyuan Yuhui National Education Group, Inc., Pan Global Corp., Shengtang International, Inc., Alternaturals, Inc., USA Recycling Industries, Inc., Tele Group Corp., Xenoics Holdings, Inc., Richland Resitsces International Group, Inc., AI Technology Group, Inc., Reliance Global Group, Inc., Melt, Inc., Ketdarina Corp., 3D MarkerJet, Inc., Lvpai Group Ltd., Gushen, Inc., FHT Future Technology Ltd., Inspired Builders, Inc., Houmu Holdings Ltd., Born, Inc., Changsheng International Group Ltd., Sollensys Corp., Guozi Zhongyu Capital Holdings Co.

and Cang Bao Tian Xia International Art Trade Center, Inc. Mr. Lazar currently serves as an Advisor to PROMAX Investments LLC, a position he has held since July 2022, and as an Ambassador at Large for the Arab African Council for Integration and Development, since March 2022.   He has also served as the CEO of Custodian Ventures LLC, since February 2018, and Activist Investing LLC, an actively managed private investment fund, since March 2018. Previously, Mr. Lazar served as Managing Partner at Zenith Partners International Inc., a boutique consulting firm, from July 2012 to April 2018.

Based on Mr. Lazar?s diverse knowledge of financial, legal and operations management, public company management, accounting, audit preparation, due diligence reviews and SEC regulations, its Board believes that Mr. Lazar has the appropriate set of skills to serve as a member of the Board. Avraham Ben-Tzvi (53) is the founder of ABZ Law Office, a boutique Israeli law firm specializing in corporate & securities laws, commercial law & contracts, and various civil law matters, as well as providing outsitsced general counsel services for publicly traded as well as private companies and corporations, which he established in January 2017. Mr. Ben-Tzvi served as Chief Legal Officer and General Counsel of Purple Biotech Ltd., a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, from November 2015 until April 2020.

Prior to that, Mr. Ben-Tzvi served as General Counsel and Company Secretary at Medigus Ltd., a minimally invasive endosurgical tools medical device and miniaturized imaging equipment company, from April 2014 until November 2015. Prior to that he served as an attorney at one of Israel?s leading international law firms where, amongst other corporate and commercial work, he advised companies and underwriters on various offerings by Israeli companies listing in the US and on various SEC related filings. Prior to becoming a lawyer.

Based on Mr. Ben-Tzvi?s extensive legal experience and knowledge in the fields of civil-commercial law and corporate and securities law, and his previous public company and commercial business experience, its Board believes that Mr. Ben-Tzvi has the appropriate set of skills to serve as a member of the Board.   David Natan (70) currently serves as President and Chief Executive Officer of Natan & Associates, LLC, a consulting firm offering chief financial officer services to public and private companies in a variety of industries, since 2007. From February 2010 to May 2020, Mr. Natan served as Chief Executive Officer of ForceField Energy, Inc. From February 2002 to November 2007, Mr. Natan served as Executive Vice President of Reporting and Chief Financial Officer of PharmaNet Development Group, Inc., a drug development services company, and, from June 1995 to February 2002, as Chief Financial Officer and Vice President of Global Technovations, Inc., a manufacturer and marketer of oil analysis instruments and speakers and speaker components.

Prior to that, Mr. Natan served in various roles of increasing responsibility with Deloitte & Touche LLP, a global consulting firm. Additionally in November 2023, Mr. Natan was appointed to the board of directors and Audit Committee Chair of Minim, Inc. In December 2022, Mr. Natan was appointed to the board of Directors and Audit Committee Chair of Vivakor Inc. and served until December 2023. Previously, Mr. Natan served as Chairman of the Board of Directors of ForceField Energy, Inc., from April 2015 to May 2020, and as a member of the Board of Directors of Global Technovations, Inc., from December 1999 to December 2001.

Mr. Natan holds a B.A. in Economics from Boston University. Based on Mr. Natan?s extensive experience, its Board believes that Mr. Natan has the appropriate set of skills to serve as a member of the Board.   Matthew C. McMurdo (52) has served as Managing Member of McMurdo Law Group, LLC, a corporate law practice, since 2010.

Previously, Mr. McMurdo was a Partner at Nannarone & McMurdo, LLP, a boutique law firm, from 2008 to 2010. In addition, Mr. McMurdo served as General Counsel of Berkley Asset Management LLC, the general partner of a real estate fund focused on opportunistic and distressed real estate assets, from 2011 to 2013. Mr. McMurdo was Of-Counsel at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., from 2007 to 2008 and an associate at Greenberg Traurig, LLP from 2006 to 2007.

Since August 2022, Mr. McMurdo has served as a director of Titan Pharmaceuticals, Inc., where he serves on the audit, compensation (chair), and nominating committees. On December 28, 2023, Mr. McMurdo was appointed to the board of directors of Minim Inc, where he serves on the compensation and nominating committees. Mr. McMurdo holds a B.S. in Finance from Lehigh University and a J.D., cum laude, from Benjamin N. Cardozo School of Law.

Based on Mr. McMurdo?s extensive experience and knowledge in the fields of corporate and securities law, and his previous public company and commercial business experience, its Board believes that Mr. McMurdo has the appropriate set of skills to serve as a member of the Board.